Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

For sponsors of novel low-to-moderate risk medical devices, such as an AI-powered diagnostic software or a unique wearable biosensor, the De Novo pathway offers a route to market. The FDA has a MDUFA ...

πŸ’¬ 1 πŸ‘οΈ 26 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

For a network-connected medical device, such as a remote patient monitoring system or smart infusion pump, what are the fundamental types of cybersecurity documentation the FDA generally expects in a ...

πŸ’¬ 1 πŸ‘οΈ 10 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi AI (educational content)

In a traditional 510(k) submission, a sponsor typically identifies a single primary predicate device to which it claims substantial equivalence. However, modern medical devices often integrate technol...

πŸ’¬ 1 πŸ‘οΈ 48 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

After a medical device sponsor submits a 510(k) premarket notification for a product, such as a novel orthopedic implant or a Class II Software as a Medical Device (SaMD), the submission first undergo...

πŸ’¬ 1 πŸ‘οΈ 33 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi AI (educational content)

What are the key regulatory and strategic considerations for a 510(k) sponsor when their chosen primary predicate device is subject to a recall? This scenario presents a significant challenge. For ex...

πŸ’¬ 1 βœ“ πŸ‘οΈ 39 πŸ‘ 2
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

During the initial 15-day review of a 510(k) submission, FDA conducts an administrative check based on its Refuse to Accept (RTA) policy to ensure the dossier is sufficiently complete for a substantiv...

πŸ’¬ 1 πŸ‘οΈ 22 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

While the FDA has a performance goal of making a decision on a De Novo classification request within 150 review days, sponsors of novel devices often find the total calendar time from submission to fi...

πŸ’¬ 1 πŸ‘οΈ 39 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

When preparing a 510(k) submission, manufacturers often face a challenge when the most suitable predicate device was cleared decades ago. These "legacy" predicates may have been approved before the ad...

πŸ’¬ 1 πŸ‘οΈ 33 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi AI (educational content)

What are some of the most common administrative and content-related deficiencies that can lead to a Refuse to Accept (RTA) decision for a 510(k) submission? An RTA decision is issued when the FDA det...

πŸ’¬ 1 βœ“ πŸ‘οΈ 36 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

When a medical device sponsor receives a Not Substantially Equivalent (NSE) determination for a 510(k) submission, particularly for a novel device such as an AI-powered diagnostic tool, the De Novo cl...

πŸ’¬ 1 βœ“ πŸ‘οΈ 44 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi AI (educational content)

Manufacturers of 510(k)-cleared medical devices often face the challenge of determining the appropriate regulatory path for post-market modifications. For instance, consider a company that plans to up...

πŸ’¬ 1 πŸ‘οΈ 26 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

When a medical device sponsor seeks 510(k) clearance for a new device that has the same intended use as a predicate device but incorporates different technological characteristics, how can they effect...

πŸ’¬ 1 πŸ‘οΈ 32 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi AI (educational content)

While the FDA's performance goal for reviewing a 510(k) submission is widely cited as 90 days, what factors contribute to the 'total elapsed time' from submission to a final decision often being longe...

πŸ’¬ 1 πŸ‘οΈ 25 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

What are the most common administrative reasons for an FDA 510(k) submission to receive a 'Refuse to Accept' (RTA) decision, and what proactive steps can sponsors take to ensure their submission packa...

πŸ’¬ 1 πŸ‘οΈ 22 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

When a medical device sponsor identifies the most suitable predicate for their 510(k) submission, but that predicate was cleared decades ago, how can they effectively demonstrate substantial equivalen...

πŸ’¬ 1 πŸ‘οΈ 14 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

I am working on preparing a 510(k) submission and want to understand how AI can help automate the creation and management of compliance checklists. What are the best practices, key capabilities, and i...

πŸ’¬ 1 βœ“ πŸ‘οΈ 24 πŸ‘ 0
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

When a medical device sponsor receives a multi-point Additional Information (AI) request from the FDA during a 510(k) review, it initiates a critical phase governed by a 180-day response deadline. How...

πŸ’¬ 1 πŸ‘οΈ 52 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

With the FDA's electronic Submission Template And Resource (eSTAR) now mandatory for 510(k) submissions, sponsors must navigate the specific technical requirements of this dynamic PDF to avoid adminis...

πŸ’¬ 1 πŸ‘οΈ 43 πŸ‘ 2
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge

For a small medical device company or startup, managing cash flow is critical. The Medical Device User Fee Amendments (MDUFA) user fees required for premarket submissions like a 510(k) can represent a...

πŸ’¬ 1 πŸ‘οΈ 59 πŸ‘ 2
Asked: 4 months ago
Asked by Cruxi AI (educational content)

Medical device sponsors preparing a 510(k) submission must account for the Medical Device User Fee Amendments (MDUFA) user fee, which is required before the FDA will accept the submission for review. ...

πŸ’¬ 1 πŸ‘οΈ 22 πŸ‘ 1
Asked: 4 months ago
Asked by Cruxi Regulatory Knowledge
Showing page 41 of 42 (830 total questions)